The Hippo-Yes Association Protein Pathway in Liver Cancer
Open Access
- 1 January 2013
- journal article
- review article
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2013, 1-7
Abstract
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and the third leading cause of cancer mortality. Despite continuing development of new therapies, prognosis for patients with HCC remains extremely poor. In recent years, control of organ size becomes a hot topic in HCC development. The Hippo signaling pathway has been delineated and shown to be critical in controlling organ size in both Drosophila and mammals. The Hippo kinase cascade, a singling pathway that antagonizes the transcriptional coactivator Yes-associated protein (YAP), plays an important role in animal organ size control by regulating cell proliferation and apoptosis rates. During HCC development, this pathway is likely inactivated in tumor initiated cells that escape suppressive constrain exerted by the surrounding normal tissue, thus allowing clonal expansion and tumor development. We have reviewed evolutionary changes in YAP as well as other components of the Hippo pathway and described the relationships between YAP genes and HCC. We also discuss regulation of transcription factors that are up- and downstream of YAP in liver cancer development.Keywords
Funding Information
- National Natural Science Foundation of China (81101579, 81072005)
- National Natural Science Foundation of China (81101579, 81072005)
This publication has 71 references indexed in Scilit:
- Inhibition of Aβ25–35-induced cell apoptosis by Low-power-laser-irradiation (LPLI) through promoting Akt-dependent YAP cytoplasmic translocationCellular Signalling, 2012
- Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinomaOral Oncology, 2011
- NPHP4, a cilia-associated protein, negatively regulates the Hippo pathwayJournal of Cell Biology, 2011
- Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skinProceedings of the National Academy of Sciences, 2011
- Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein–mediated activationHepatology, 2010
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 OncogeneCancer Cell, 2009
- Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: A feasibility studyInternational Journal of Urology, 2008
- YAP1 Increases Organ Size and Expands Undifferentiated Progenitor CellsCurrent Biology, 2007
- Multiple Microalterations Detected at High Frequency in Oral CancerCancer Research, 2005
- Primitive neuroectodermal tumor of the cervix uteri: A case reportGynecologic Oncology, 2005